Navigation Links
Prasco Announces New, Expanded Roles for Key Executives

CINCINNATI, Dec. 6, 2011 /PRNewswire/ -- Prasco Chairman, Mr. E. Thomas Arington, announced today that Mr. Christopher H. Arington has been promoted to vice chairman and chief executive officer of Prasco.  He also announced the promotion of Mr. David Vucurevich, R.Ph. to president, chief operating officer, Mr. David Furniss as chief financial officer, and Mr. Chris Gilmore vice president, strategic business ventures.

"I am extremely pleased to announce these management changes," said E. Thomas Arington.  "As one of the founders of Prasco, Chris has played a critical role in the development and evolution of the company from day-to-day operations to the larger strategic picture," Arington said.  "Mr. Vucurevich brings extensive experience in the pharmaceutical industry, as well as a 'get it done' management style and a commitment to excellence, which is so appropriate for Prasco at this point in time. As CFO, Mr. David Furniss brings financial acumen and over twenty years of pharmaceutical industry experience.  Mr. Furniss, along with Mr. Chris Gilmore, a former Prasco Authorized Generics Business executive, will play key roles in developing and implementing new business opportunities, including acquisitions," Arington concluded.

"It is an honor to accept the position as Prasco CEO and to join Mr. David Vucurevich, in leading Prasco forward," said Chris Arington, CEO.  "I am extremely pleased with Prasco's existing leadership team and we look forward to expanding Prasco's role in the pharmaceutical industry."

About Prasco Laboratories - Prasco, the Authorized Generics company, is the privately held healthcare company located in Mason, Ohio, that specializes in Authorized Generics. Prasco Authorized Generics provide patients with the identical brand drug experience at a price that competes with generics. Prasco Authorized Generics also simplify interactions between pharmacists and consumers because they are identical to branded drugs. Moreover, Prasco Authorized Generics offer brand pharmaceutical companies a strategic lifecycle management solution.  For more information, visit

SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
2. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
3. Prasco® Launches Authorized Generic with Shionogi Inc.
4. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
5. Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
6. Prasco to Market Authorized Generic of ZEGERID®
7. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
8. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
9. CPhI Conferences Announces Details of 5th Annual PharmaSource Conference in Munich
10. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
11. AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life
Post Your Comments:
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):